Semler Scientific Inc (SMLR) VP Daniel E. Conger Sells 5,000 Shares of Stock

Share on StockTwits

Semler Scientific Inc (OTCMKTS:SMLR) VP Daniel E. Conger sold 5,000 shares of Semler Scientific stock in a transaction dated Thursday, September 6th. The shares were sold at an average price of $25.78, for a total transaction of $128,900.00. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Shares of SMLR traded up $2.49 during trading hours on Friday, reaching $29.69. 155,326 shares of the company traded hands, compared to its average volume of 23,567. The firm has a market capitalization of $164.16 million, a price-to-earnings ratio of 85.00 and a beta of 0.73. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 0.03. Semler Scientific Inc has a 12 month low of $3.30 and a 12 month high of $27.50.

Semler Scientific (OTCMKTS:SMLR) last posted its quarterly earnings data on Tuesday, July 31st. The medical equipment provider reported $0.19 EPS for the quarter, topping the consensus estimate of $0.08 by $0.11. Semler Scientific had a net margin of 13.35% and a negative return on equity of 127.01%. The business had revenue of $5.48 million for the quarter, compared to analyst estimates of $4.69 million. research analysts forecast that Semler Scientific Inc will post 0.72 EPS for the current fiscal year.

Separately, Lake Street Capital assumed coverage on shares of Semler Scientific in a research note on Monday, July 30th. They set a “buy” rating and a $27.00 target price on the stock.

About Semler Scientific

Semler Scientific, Inc develops, manufactures, and markets patented products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. Its products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition; and WellChec, a multi-test service platform to evaluate patients with various chronic diseases.

See Also: Earnings Per Share

Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with's FREE daily email newsletter.

Leave a Reply